Agile Vaccine Clinical Development Expertise

Accelerating vaccine development to prevent and treat virulent diseases

Vaccine developers worldwide are faced with the challenge of quickly and safely advancing their vaccines through the clinical development and approval process to prevent millions of deaths every year.   Infectious disease pandemics like Ebola, MERS, and COVID-19 come to mind currently, requiring a rapid response to regional or global outbreaks. Equally important are vaccines to prevent or treat cancers, viral, and bacterial infections that impact the length or quality of human lives.  

At Veristat, we have the scientific-minded experts ready to advance your vaccine through the regulatory hurdles, recruitment challenges, and approval process to safely bring vaccines to market. 

Understanding Vaccine Trials

We understand that vaccine development has a unique set of challenges, so Veristat has assembled an extraordinary team of scientific-minded experts who have planned and executed over 140 vaccine projects and supported numerous marketing applications.  

Whether a vaccine to prevent or treat cancer recurrence or progression, or rapidly responding to an infectious disease outbreak, like the ongoing COVID-19 pandemic, we solve the problems that arise in testing immunotherapy vaccines, live or inactivated viral vaccines, or even the newest DNA vaccines.

At Veristat, our experienced teams are poised to plan and implement these efforts quickly providing:     
Veristat_icon_vaccine

> 140

vaccine projects supported
Veristat_icon_oncology-216-1

> 40

cancer vaccine projects supported
Veristat_icon_data manager

> 8

marketing applications prepared for vaccines

 Cancer and Virus Vaccine Experience

Knowledge From a Broad Range of Vaccine Experience
   Botulinum Vaccine    Lymphoma
   Breast Cancer    Melanoma
   C Difficile    Metastatic Breast Cancer
   Cervical Cancer    Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
   Colorectal Cancer    Non-Small Cell Lung Cancer
   COVID-19    Pancreatic Cancer
   Ebola    Pandemic Flu
   Gastric Cancer    Prostate Cancer
   Glioblastoma    Renal Cell Cancer
   Head and Neck Squamous Cell Carcinoma (HNSCC)    Respiratory Syncytial Virus
   Hepatitis A    Shingles -Varicella-Zoster Virus (VZV)
   Hepatitis B    Smallpox
   Herpes (HSV2)    Thyroid Cancer
   Human Papilloma Virus (HPV)    Typhoid Fever
   Influenza    Vulva Cancer
   Liver Metastasis    Yellow Fever

 

Learn More with These Resources

Case Study

Rescue Patient Recruitment for Lagging Trial

Patient recruitment delays are common challenges in clinical trials that can lead to costly delays. In fact, nearly 80 percent of patient recruitment timelines in clinical trials are not ...

Download

Fact Sheet

Respiratory Fact Sheet

Veristat is a leader in the conduct of respiratory studies. With a wealth of experience, understanding, and knowledge of the challenges of running respiratory studies, we are able to ...

Download

Webinar Video Replay

Managing E6R2 Compliance As it Relates to Risk

Watch our webinar to learn about innovative approaches to remote-based and risk-based monitoring, best practices for risk assessment and risk management to conduct risk-based monitoring ...

Download
Request A Proposal
  • Privacy Policy
  • ©2006 - 2021 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat, LLC. All other trademarks are the property of their respective owners.